Clinical Trials
Page 1 • 10 itemsAccess global clinical trial data, regulatory updates, and competitive intelligence for strategic pharma R&D and investment decisions.
NMPA Clinical Trial Regulations: Impact on Multinational Pharma Data & Inspections
This article delves into the NMPA clinical trial regulations and their significant impact on multinational pharmaceutical data management and inspection processes.
PMDA Guideline Updates: Impact on Adaptive Trial Designs & Data Transparency
This article delves into the recent PMDA guideline updates and their implications for adaptive trial designs and data transparency in drug development.
Purdue Pharma Shutdown: $7.4B Deal Ends OxyContin Maker's Era
Purdue Pharma, the manufacturer of OxyContin, is ceasing operations as part of a $7.4 billion settlement to resolve claims related to the opioid crisis. This landmark deal signifies a major turning point in the legal and societal reckoning with the epidemic.
PMDA SAKIGAKE Designation: Accelerating Innovative Therapies in Japan
The PMDA SAKIGAKE Designation fast-tracks innovative therapies, such as XYZ Drug for cancer, enhancing patient access to groundbreaking treatments in Japan.
NMPA Foreign Clinical Trial Data: What You Need to Know
This article explores the significance of NMPA foreign clinical trial data for drug approvals, focusing on its impact on cancer therapies and regulatory compliance.
Clinical Trial Quality Management Systems: New APAC Standards & Challenges
This article delves into the latest APAC standards for clinical trial quality management systems, highlighting challenges in ensuring drug efficacy and patient safety.
China Clinical Trial Regulations: Key Insights on NMPA Reforms 2024
Discover key insights on the 2024 NMPA reforms in China, shaping clinical trial regulations and their implications for drug development in oncology and rare diseases.
Clinical Trial Regulatory Harmonization: NMPA & PMDA ICH Adoption in APAC
This article delves into the regulatory harmonization of clinical trials in APAC, focusing on NMPA and PMDA's ICH adoption to expedite drug approvals.
CAR-T Cell Therapy Japan: Regulatory Insights & Clinical Trial Landscape
This article delves into CAR-T cell therapy in Japan, highlighting regulatory frameworks and the evolving clinical trial landscape for hematologic malignancies.
HSA Clinical Trial Modernization: Singapore's New Framework for CITDs
Singapore's innovative framework for Clinical Investigation of Therapeutic Devices (CITDs) aims to modernize clinical trials, enhancing drug safety and efficacy.